Skip to main content
Fig. 2 | Thrombosis Journal

Fig. 2

From: Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

Fig. 2

Comparison of composite outcome of VTE recurrence or major bleeding in (A) the unmatched analysis, B the propensity score-matched analysis, and (C) the IPTW–weighted analysis. Abbreviations: VTE, venous thromboembolism; IPTW, inverse probability of treatment weighting; LMWH, low-molecular-weight heparin; Riva, rivaroxaban; HR, hazard ratio; CI: confidence interval

Back to article page